NANOVIRICIDES, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
NANOVIRICIDES, INC. (NNVC) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $0 for the 12-month period ending 2012-06-30, per its 10-K/A filed 2012-10-26.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2012-10-26
- NANOVIRICIDES, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2012 was $0.00.
- NANOVIRICIDES, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- NANOVIRICIDES, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2010 was $162.52K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month |
|---|---|
| 2012-06-30 | $0.00 10-K/A · filed 2012-10-26 |
| 2011-06-30 | $0.00 10-K/A · filed 2012-10-26 |
| 2010-06-30 | $162.52K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |